Chronic obstructive pulmonary disease (COPD) is one of the leading causes of death worldwide. It is characterised by airflow obstruction that is not fully reversible.1 The main aim of the drug treatments used in the management of COPD are to improve symptoms, maintain lung function, reduce the frequency and severity of exacerbations, and improve health status and exercise tolerance.2
Many patients will experience COPD exacerbations – days-long episodes of increased dyspnoea, cough, and sputum production. COPD exacerbations result in increased use of bronchodilators, impaired function and decreased enjoyment of life; more severe exacerbations require systemic steroids, antibiotics, and sometimes hospitalisation.
Please login or register to read the rest of the article and to have access to downloads and comments.